Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.